TFF Pharmaceuticals, Felix Biotechnology sign LOI for collaboration, development and licence agreement

This article was originally published here

Under this proposed CDLA agreement, Felix Biotechnology would obtain a worldwide license to TFF Pharmaceuticals’ Thin Film Freezing technology to develop and manufacture dry powder formulations of a

The post TFF Pharmaceuticals, Felix Biotechnology sign LOI for collaboration, development and licence agreement appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply